Suppr超能文献

韦格纳肉芽肿病。环磷酰胺治疗患者的长期随访

Wegener's granulomatosis. Long-term followup of patients treated with cyclophosphamide.

作者信息

Reza M J, Dornfeld L, Goldberg L S, Bluestone R, Pearson C M

出版信息

Arthritis Rheum. 1975 Sep-Oct;18(5):501-6. doi: 10.1002/art.1780180513.

Abstract

Ten patients with Wegener's granulomatosis were treated with cyclophosphamide and followed for periods up to 7 years. In all cases cyclophosphamide induced complete remissions. The mean duration of remission (to date) was 38 months. Six patients have been in remission for a mean of 46 months after cyclophosphamide was discontinued; 2 have been disease-free for 7 years. Of the 10 patients treated, only 1 relapsed and she responded to a second course of cyclophosphamide. These results indicate that cyclophosphamide is the drug of choice in Wegener's granulomatosis. The long-term effectiveness of this drug suggests that it may induce permanent remissions in certain patients with Wegener's granulomatosis.

摘要

10例韦格纳肉芽肿患者接受了环磷酰胺治疗,并随访了长达7年的时间。在所有病例中,环磷酰胺均诱导了完全缓解。缓解的平均持续时间(至今)为38个月。6例患者在停用环磷酰胺后平均缓解了46个月;2例已无病生存7年。在接受治疗的10例患者中,只有1例复发,她对第二疗程的环磷酰胺有反应。这些结果表明,环磷酰胺是韦格纳肉芽肿的首选药物。该药物的长期有效性表明,它可能会使某些韦格纳肉芽肿患者获得永久性缓解。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验